A Oncoclinics (ONCO3) announced this Tuesday (6) that it intends to carry out a primary and secondary public offering of shares, according to a material fact to the market.
“The potential offer, as well as any operation of this type, is subject, among other factors, to the conditions of the Brazilian capital market, to obtaining the necessary approvals”, said the company, also citing favorable political and macroeconomic conditions as factors.
MARKET TURN: Your daily program from Monday to Friday, always at noon to bring you all the news that boils in the financial market and the analyzes that drive your investments! Save the link and don’t miss it!
Check out the advertisement of Oncoclínicas:
Source: Moneytimes
I am an author and journalist with a focus on market news. I have worked for a global news website for the past two years, writing articles on a range of topics relating to the stock market. My work has been published in international publications and I have delivered talks at both academic institutions and business conferences around the world.
